A carregar...
NKT cell adjuvants in therapeutic vaccines against hematological cancers
Immune adjuvants aimed at initiating or re-activating host immunity against poorly immunogenic cancers represent a potential tool for immunotherapy. By employing the natural killer T (NKT) cell agonist α-galactosylceramide in a whole tumor cell therapeutic vaccine approach, we have achieved potent s...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3583928/ https://ncbi.nlm.nih.gov/pubmed/23482240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22615 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|